Page 66 - Basic Monitoring in Canine and Feline Emergency Patients
P. 66

Table 3.6.  Continued.
  VetBooks.ir  Drug     General indications     Dose (dog)               Dose (cat)
                                                                         IV/IM/SQ: 0.01–0.02 mg/kg
             Glycopyrrolate
                        Hemodynamically relevant
                                                IV/IM/SQ: 0.01–0.02 mg/kg
                         bradyarrhythmias
             Theophylline  Long-term treatment of SSS;   PO: 10 mg/kg q12h  PO: 10 mg/kg q12h
                         bronchodilation
             Propantheline Long-term treatment of SSS  PO: 0.25–0.5 mg/kg q8-12h  –
             Hyoscyamine  Long-term treatment of SSS  P: 0.003–0.006 mg/kg q8h  –
             Other anti-arrhythmic medications
             Magnesium   Adjunct treatment of VT/VPCs  IV: 0.3 mEq/kg over 15 min  IV: 0.3 mEq/kg over 15 min
              chloride
              (or sulfate)
             Digoxin    Heart rate reduction in AF   IV: loading protocol of 2.5 μg/kg  PO: 5 μg/kg q48h
                         (especially if concurrent CHF)  slow bolus repeated hourly ×
                                                  4 hours (total 10 μg/kg)
                                                PO: 3–5 μg/kg q12h
            AF, Atrial fibrillation; CHF, congestive heart failure; CRI, continuous rate infusion; IM, intramuscular; IV, intravenous; PO, by mouth;
            SQ, subcutaneous; SNS, sympathetic nervous system; SSS, sick sinus syndrome; SVPC, supraventricular premature complex; SVT,
            supraventricular tachycardia; VPC, ventricular premature complex; VT, ventricular tachycardia.


            also occur in patients with noncardiac diseases,   Therefore, P waves of normal morphology may be
            including electrolyte derangements (hypokalemia,   noted intermittently between ventricular QRS
            hypomagnesemia), splenic disease, gastric dilata-  complexes, with no consistent temporal relation-
            tion-volvulus, and sepsis. Another variant of ven-  ship to QRS complexes (see arrows in  Fig. 3.9).
            tricular ectopy is called accelerated idioventricular   Most P waves are not visible because they occur
            rhythm (AIVR). AIVR, sometimes oxymoronically   simultaneously with QRS complexes and are thus
            called ‘slow VT,’ refers to a ventricular rhythm that   ‘hidden’ on the ECG. VT is often most often seen
            occurs at heart rates close to the sinus rate of the   as an intermittent rhythm; that is, the patient has
            patient (e.g. <140  bpm in the dog).  AIVR most   an underlying normal sinus rhythm with frequent
            commonly occurs in patients with  noncardiac   VPCs and paroxysms of VT. If a sinus beat and
            causes of ventricular ectopy (see above) or in   VPC  occur  at  the  same  time,  wave  fronts  from
            patients under general anesthesia/sedation.   both stimuli may cause the ventricle may depolar-
            Because  the heart rate in  AIVR is similar to the   ize from both ‘above and below’ simultaneously,
            sinus rate for that patient, AIVR does not lead to   leading to an abnormal QRS complex that is a
            hemodynamic compromise and generally does not   morphologic hybrid of the patient’s ventricular
            require treatment.                           and sinus complexes. Such complexes are called
              Isolated  VPCs  are  typically  easy  to  recognize   fusion beats and can be helpful in confirming the
            because  QRS  morphology  differs  from  the  sur-  diagnosis of VT.
            rounding sinus beats; however, sustained VT may   Ventricular ectopy warrants treatment if the
            be more difficult to identify without normal sinus   ventricular arrhythmias  lead to hemodynamic
            beats present for comparison. VT is perfectly reg-  compromise (hypotension) or place the patient at
            ular  (identical  R–R  intervals)  unless  there  are   risk for sudden cardiac death. The first-line emer-
            multiple ventricular foci involved, in which case   gency treatment for  VT in dogs is intravenous
            QRS morphology also varies between beats (poly-  lidocaine; adjunctive treatments if lidocaine is
            morphic VT;  see  Fig. 3.10). Because the ectopic   unsuccessful include procainamide or amiodarone
            beats originate within the ventricles, the presence   (see  Table 3.6). In cats, lidocaine is generally
            of VT does not affect the firing of the SA node; the   avoided  or  used  at  much  lower  doses  due  to
            atria and ventricles are controlled by two inde-  adverse effects. Hypokalemia and hypomagne-
            pendent ‘pacemakers’  (termed  AV dissociation).   semia  should  also be  corrected  if  present.  Long-


             58                                                                           J.L. Ward
   61   62   63   64   65   66   67   68   69   70   71